PDCD1LG2 and neoplasm: The 10 patients with tumor samples available had PDL1 and PDL2 amplifications, as revealed by fluorescence in situ hybridization experiments, and the levels of PD-L1 and PD-L2 were increased, as detected using immunohistochemical analysis [21].